Pharmagupshup,pharmacy,free gpat material,niper,free niper material, pharma vacancy, pharma jobs, pharmacy seminar,pharma conference,pharma awards,pharma books,pharma study material,pharma services, pharma news,pharma colleges,pharma acts,sops

Tuesday, October 9, 2012

Free Download Active Pharmaceutical Ingredients Development, Manufacturing, and Regulation edited by Stanley H. Nusim S. H. Nusim Associates, Inc. Aventura, Florida, U.S.A. Boca Raton -Free Pharmacy Books download from pharmagupshup.in





Contents

Preface . . . . iii
Contributors . . . . xiii
1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
Stanley H. Nusim
I. Consolidation and Integration . . . . 2
II. Quality . . . . 2
III. Potency . . . . 5
IV. Computer Control and Automation . . . . 6
V. Summary . . . . 7
2. Process Development . . . . . . . . . . . . . . . . . . . . . 9
Carlos B. Rosas
I. Introduction . . . . 9
II. The Bulk Drug Process as Part of the
Drug Development Program . . . . 13
III. From the Bench to the Pilot
Plant and Beyond . . . . 39
IV. The Physicochemical Attributes of the
Bulk Drug . . . . 61
V. The Process Body of Knowledge . . . . 65
VI. Processing Responsibility in Bulk Drug
Process Development . . . . 73
VII. Outsourcing in Bulk Drug
Process Development . . . . 89
vii
VIII. In Closing . . . . 89
References . . . . 90
3. Bulk Drugs: Process Design, Technology Transfer,
and First Manufacture . . . . . . . . . . . . . . . . . . . 93
Carlos B. Rosas
I. Introduction . . . . 93
II. The Process Design Task in Bulk
Drugs . . . . 96
III. Technology Transfer of the Bulk Drug
Process and First Manufacture . . . . 106
IV. In Closing—The Processing Technologies of
Bulk Drugs . . . . 123
References . . . . 125
4. Design and Construction of Facilities . . . . . . . 127
Steven Mongiardo and Eugene Bobrow
I. Introduction . . . . 127
II. Business Requirements . . . . 129
III. Developing the Preliminary Scope . . . . 132
IV. Utilities and Building Systems . . . . 137
V. Preliminary Scope Deliverables . . . . 138
VI. Design Development . . . . 142
VII. Utilities . . . . 147
VIII. Safety . . . . 150
IX. Current Good Manufacturing Practices
Requirements . . . . 150
X. Qualification Plan . . . . 151
XI. Expansion Capabilities . . . . 152
XII. Hazard and Operability Analysis . . . . 152
XIII. Execution Strategy and Planning . . . . 154
XIV. Procurement Strategy . . . . 156
XV. Construction Management . . . . 161
XVI. Start–Up Acceptance . . . . 162
XVII. Project Turnover and Installation
Qualification . . . . 163
XVIII. Conclusions . . . . 165
References . . . . 166
viii Contents
5. Regulatory Affairs . . . . . . . . . . . . . . . . . . . . . . . 167
John Curran
I. Introduction . . . . 167
II. Requirements for Submission of
Regulatory CMC Documents . . . . 169
III. Contents of Regulatory
Submissions—API Sections . . . . 173
IV. Registration Samples . . . . 191
V. The Review and Approval Process . . . . 192
VI. Preapproval Inspections . . . . 195
VII. Postapproval Change Evaluations . . . . 196
VIII. The Future . . . . 199
IX. Helpful References . . . . 200
6. Validation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 203
James Agalloco and Phil Desantis
I. History . . . . 203
II. Definition of Validation . . . . 205
III. Regulations . . . . 206
IV. Application of Validation . . . . 206
V. Life Cycle Model . . . . 206
VI. Validation of New Products . . . . 207
VII. Validation of Existing Products . . . . 208
VIII. Implementation . . . . 209
IX. Bulk Pharmaceutical Chemical
Validation . . . . 211
X. In-Process Controls . . . . 220
XI. Cleaning Validation . . . . 222
XII. Computerized Systems . . . . 225
XIII. Procedures and Personnel . . . . 225
XIV. Validation of Sterile Bulk Production . . . . 225
XV. Conclusion . . . . 231
References . . . . 231
7. Quality Assurance and Control . . . . . . . . . . . . 235
Michael C. VanderZwan
I. Introduction . . . . 235
II. Defining and Assuring the Quality of the Active
Pharmaceutical Ingredient . . . . 240
Contents ix
III. The Regulations for Quality . . . . 245
IV. The Quality Control and Quality
Assurance Department . . . . 273
Appendix A . . . . 280
8. Plant Operations . . . . . . . . . . . . . . . . . . . . . . . . 285
Stanley H. Nusim
I. Plant Organization . . . . 285
II. Batch vs. Continuous . . . . 286
III. Dedicated vs. Shared Manufacturing
Facilities . . . . 288
IV. Shift Operations . . . . 288
V. Sterile Operations . . . . 291
VI. Clean Room . . . . 294
VII. Cost Control . . . . 296
VIII. Fixed Overhead Absorption . . . . 299
IX. Safety . . . . 300
X. Environmental . . . . 303
9. Materials Management . . . . . . . . . . . . . . . . . . . 305
Victor Catalano
I. Introduction . . . . 305
II. Production Planning . . . . 306
III. Inventory Management . . . . 307
IV. Purchasing=Supply Management . . . . 308
V. Distribution=Transportation . . . . 315
VI. Information Technology . . . . 316
VII. Quality Management . . . . 317
References . . . . 318
10. Plant Maintenance . . . . . . . . . . . . . . . . . . . . . . 323
Raymond J. Oliverson
I. Introduction . . . . 323
II. Strategic Plan . . . . 324
III. Reliability-Balanced Scorecards . . . . 325
IV. Maintenance Basics . . . . 327
V. Condition Monitoring . . . . 329
VI. Operator-Driven Reliability . . . . 330
VII. Reliability Engineering . . . . 331
VIII. Risk Management . . . . 333
IX. Summary . . . . 334



Share:

0 comments:

Post a Comment

Copyright © Pharmagupshup | Powered by Pharmagupshup Hitesh Katariya